This content is in French.
Rethinking Breast Cancer Surgery in Older Women
20 novembre 2026

Surgery remains the standard treatment for older women with early-stage, oestrogen receptor-positive (ER-positive) breast cancer. However, surgery may pose significant risks for patients with frailty, multiple health conditions or limited life expectancy.
Primary endocrine therapy (PET) offers a less invasive approach. It uses hormone-blocking medicines, such as tamoxifen or aromatase inhibitors, to control tumour growth without initial surgery.
Traditionally, PET has been reserved for patients considered unsuitable for surgery. However, emerging evidence suggests that tumour characteristics may help identify women who could benefit from long-term endocrine treatment.
Sign in to read the rest
Reserved for healthcare professionals, free registration.


